Jim Cramer says it's hard to explain why stocks opened lower, but he thinks investors should have some conviction and look for buying opportunities.

Apellis Pharmaceuticals, Harley-Davidson, Dillard's, Children's Place and Harmony Gold are five top gainers for Monday.

Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.

Editas is initiated with a sell rating and $20 price target at Goldman Sachs.

Jim Cramer says this market environment is a strange merger of resilience, complacency and hubris. He explains how this feeds a stock rally.

Workers demand for their needs to be met.

The residential real estate market has stumbled, after soaring in the first 18 months of the covid pandemic.

Facebook and Instagram's parent company has a plan to take over a new segment.